Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sitaram Emani, M.D.

Co-Author

This page shows the publications co-authored by Sitaram Emani and Sirisha Emani.
Connection Strength

7.449
  1. Thromboelastography During Rewarming for Management of Pediatric Cardiac Surgery Patients. Ann Thorac Surg. 2021 Mar 02.
    View in: PubMed
    Score: 0.957
  2. Platelet Inhibition With IV Glycoprotein IIb/IIIa Inhibitor to Prevent Thrombosis in Pediatric Patients Undergoing Aortopulmonary Shunting. Pediatr Crit Care Med. 2020 06; 21(6):e354-e361.
    View in: PubMed
    Score: 0.909
  3. Thromboelastography Is Associated With Surrogates for Bleeding After Pediatric Cardiac Operations. Ann Thorac Surg. 2018 09; 106(3):799-806.
    View in: PubMed
    Score: 0.789
  4. Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2017 11; 154(5):1723-1730.
    View in: PubMed
    Score: 0.741
  5. Intravenous GPIIb/IIIa Inhibitor for Secondary Prevention of Shunt Thrombosis in a Pediatric Patient. Ann Thorac Surg. 2015 Jun; 99(6):e151-3.
    View in: PubMed
    Score: 0.643
  6. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2014 Sep; 148(3):810-4; discussion 814-6.
    View in: PubMed
    Score: 0.601
  7. Hypercoagulability panel testing predicts thrombosis in neonates undergoing cardiac surgery. Am J Hematol. 2014 Feb; 89(2):151-5.
    View in: PubMed
    Score: 0.577
  8. Hypercoagulability markers predict thrombosis in single ventricle neonates undergoing cardiac surgery. Ann Thorac Surg. 2013 Aug; 96(2):651-6.
    View in: PubMed
    Score: 0.562
  9. Novel microfluidic platform for automated lab-on-chip testing of hypercoagulability panel. Blood Coagul Fibrinolysis. 2012 Dec; 23(8):760-8.
    View in: PubMed
    Score: 0.540
  10. Gene regulation of extracellular matrix remodeling in human bone marrow stem cell-seeded tissue-engineered grafts. Tissue Eng Part A. 2011 Oct; 17(19-20):2379-88.
    View in: PubMed
    Score: 0.488
  11. Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice. J Extra Corpor Technol. 2019 Dec; 51(4):221-226.
    View in: PubMed
    Score: 0.219
  12. Evaluation of Placental Mesenchymal Stem Cell Sheets for Myocardial Repair and Regeneration. Tissue Eng Part A. 2019 06; 25(11-12):867-877.
    View in: PubMed
    Score: 0.203
  13. Multipotency of mouse trophoblast stem cells. Stem Cell Res Ther. 2020 02 13; 11(1):55.
    View in: PubMed
    Score: 0.056
  14. Elevated preoperative von Willebrand factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease. J Thromb Haemost. 2017 12; 15(12):2306-2316.
    View in: PubMed
    Score: 0.047
  15. Relationship Between Transfusion of Blood Products and the Incidence of Thrombotic Complications in Neonates and Infants Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2017 Dec; 31(6):1943-1948.
    View in: PubMed
    Score: 0.046
  16. Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering. Acta Biomater. 2015 Mar; 14:84-95.
    View in: PubMed
    Score: 0.039
  17. A comparison of human smooth muscle and mesenchymal stem cells as potential cell sources for tissue-engineered vascular patches. Tissue Eng Part A. 2012 May; 18(9-10):986-98.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.